Inflammatory Biomarkers as Early Predictors of Complications in Infectious Diseases

Main Article Content

Mujahid Hassan
Nimra Komal
Mahpara Safdar
Muhammad Jamil Mughal
Munawar Ali Awan
Rizwan Ali Tunio

Abstract

We assessed inflammatory biomarkers on admission to predict infectious complications within 3 days. Between October 2024 and July 2025, we recruited 95 patients between the ages of 18 and 65 at three EDs in Pakistan. Biomarkers (CRP, PCT, ferritin, and neutrophil to lymphocyte ratio) were measured within 2 hours of ED arrival. We assessed the development of infectious complications using the SOFA score and defined criteria for shock and Acute Respiratory Distress Syndom (ARDS). We compared the groups, performed correlation analysis and assessed the biomarkers using Receiver Operating Characteristic Curves (ROC). About 37.9% of the study population developed an infectious complication. Participants with complications had a significantly higher level of all 4 biomarkers (p<0.001). The area under the ROC curve was 0.91 (95% CI 0.85-0.97) for PCT and 0.85 (95% CI 0.77-0.93) for CRP. An area under the ROC curve of 0.94 (95% CI 0.89-0.98) was observed for the two biomarkers together. A positive correlation was found between the maximum SOFA score and PCT (r=0.785). Our study showed that all 4 biomarkers had prognostic value, and the value was highest for PCT.

Article Details

Section

Articles

How to Cite

[1]
Mujahid Hassan et al. 2026. Inflammatory Biomarkers as Early Predictors of Complications in Infectious Diseases. Journal of Health, Wellness and Community Research. 4, 6 (Mar. 2026), 1–6. DOI:https://doi.org/10.61919/fy43y766.

References

1. Llitjos JF, Carrol ED, Osuchowski MF, Bonneville M, Scicluna BP, Payen D, et al. Enhancing sepsis biomarker development: key considerations from public and private perspectives. Crit Care. 2024;28:238. doi: 10.1186/s13054-024-05032-9.

2. Plata-Menchaca EP, Ruiz-Rodríguez JC, Ferrer R. Early diagnosis of sepsis: the role of biomarkers and rapid microbiological tests. Semin Respir Crit Care Med. 2024;45(4):479–90.

3. D’Onofrio V, Heylen D, Pusparum M, Grondman I, Vanwalleghem J, Meersman A, et al. A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis. J Intensive Care. 2022;10:13. doi: 10.1186/s40560-022-00602-x.

4. Zaki HA, Bensliman S, Bashir K, Iftikhar H, Fayed MH, Salem W, et al. Accuracy of procalcitonin for diagnosing sepsis in adult patients admitted to the emergency department: a systematic review and meta-analysis. Syst Rev. 2024;13:37. doi: 10.1186/s13643-023-02432-w.

5. Liang P, Yu F. Value of CRP, PCT, and NLR in prediction of severity and prognosis of patients with bloodstream infections and sepsis. Front Surg. 2022;9:857218. doi: 10.3389/fsurg.2022.857218.

6. Zeng G, Chen D, Zhou R, Zhao X, Ye C, Tao H, et al. Combination of C-reactive protein, procalcitonin, IL-6, IL-8, and IL-10 for early diagnosis of hyperinflammatory state and organ dysfunction in pediatric sepsis. J Clin Lab Anal. 2022;36(7):e24505.

7. Tang Y, Li Y, Sun J, Pan H, Yao F, Jiao X. Selection of an optimal combination panel to better triage COVID-19 hospitalized patients. J Inflamm Res. 2020:773–87.

8. Gregoriano C, Heilmann E, Molitor A, Schuetz P. Role of procalcitonin use in the management of sepsis. J Thorac Dis. 2020;12(Suppl 1):S5–15. doi: 10.21037/jtd.2019.11.63.